HOME >> MEDICINE >> NEWS
TB Alliance announces new drug discovery program with GlaxoSmithKline

MARCH 23 TELECONFERENCE

What:
Teleconference to provide overview on launch of broad discovery portfolio to improve the treatment of tuberculosis (TB). The program significantly enhances the TB drug pipeline by adding several novel classes of compounds that use new mechanisms of action. Briefings from the TB Alliance on status of TB drug pipeline and discussion with GlaxoSmithKline, patient and public health groups. A Q&A session for journalists follows.

Who:

  • Dr. Maria C. Freire, Global Alliance for TB Drug Development
  • Dr. Mel Spigelman, Global Alliance for TB Drug Development
  • Dr. David Pompliano, GlaxoSmithKline
  • Dr. Kenneth Castro, U.S. Centers for Disease Control and Prevention (CDC)
  • Mark Harrington, Treatment Action Group (TAG).

How:
US dial in +1-800-223-9488
International dial in +1-785-832-1523

When:
Wednesday, March 23, 2005, 10:30 AM EST

Why:
WHO estimates that 2 million people die from TB every year. The worsening TB crisis demands a new treatment paradigm based on novel drugs. This shift will only be possible with a robust and dynamic drug pipeline. The compounds from this discovery program may attack the bacillus in new ways, overcoming resistant strains and speeding time to cure.

The TB Alliance's objective is to develop an entirely new therapeutic regimen that will shorten and simplify treatment. A shorter TB regimen will improve patient compliance, increase cure rates and lower toxic side effects. A novel two-month TB regimen that is compatible with HIV treatment would help improve TB control and help in the fight on AIDS. The TB Alliance works to ensure that drugs are affordable, adopted by health practitioners and are accessible to patients who need them most.

Today's TB treatment reaches less than half of TB patients and is difficult to compl
'"/>

Contact: Brenda Timm
brenda.timm@edelman.com
212-704-4593
Edelman Public Relations
21-Mar-2005


Page: 1 2

Related medicine news :

1. Alliance for Taxpayer Access asks NIH Who really owns publicly-funded medical research?
2. Alliance congratulates Congress and NIH
3. The Gerontological Society of America announces Hartford Fellowship recipients
4. ASGE announces grant recipients in annual research awards program
5. Novartis announces collaboration with Bayer for EMSELEX
6. American College of Chest Physicians announces new Critical Care Institute
7. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
8. Department of Energy announces new agreement with USC, national labs and private company
9. ACP announces international medical fellowship
10. St. Jude Medical announces CRT patients showed improvement in the RHYTHM ICD study
11. St. Jude Medical announces PAVE and DINAMIT clinical trial results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
Breaking Medicine Technology:
Cached News: